MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuropsychiatric disturbances in Parkinson’s disease patients’ with chronic pain

G. Pavlic, I. Moldovanu, N. Diaconu, L. Rotaru (Chisinau, Republic of Moldova)

Meeting: 2016 International Congress

Abstract Number: 302

Keywords: Anxiety, Depression, Pain, Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Parkinson's disease: Non-motor symptoms

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: The study objective was to assess the neuropsychiatric profile in Moldavian Parkinson’s disease patients with chronic pain.

Background: Psychological factors can influence both the clinical picture and health related quality of life in patients with PD. Because anxiety and depression are treatable conditions, early diagnosis and treatment may help to improve quality of life in these patients.

Methods: We have included 140 consecutive PD patients from a tertiary care center, 73 patients with chronic pain and 67 without it, including 79 (56.4%) men and 61 (43.6%) women. All patients were assessed with UPDRS scale, Spielberger Trait Anxiety Inventory, Beck Depression Inventory and Parkinson’s disease Questionnaire 39 (PDQ-39), other collected variables being age, treatment duration, age at motor onset, PD phenotype and H&Y staging. Chronic pain was analyzed using a structured interview questionnaire. Windows Office Excel 2007 program was used for statistical analysis.

Results: The majority of patients presented with musculoskeletal pain (60 cases or 42.8%), 5 (3.6%) – with radicular pain, 4 (2.8%) cases presented dystonic pain and 16 (11.4%) cases have had headache. Reactive anxiety had higher values in patients with chronic pain vs. without pain (35.73±0.94 vs. 31.77±0.86, p<0.01), the same was found for trait anxiety (52.31±0.85 vs. 48.0±0.90, p<0.001). Anxiety scores correlated with pain intensity (r=0.29, p<0.01) and quality of life scores (r=0.4, p<0.001), but not with measures of disease severity. Beck depression score was higher in PD patients with chronic pain (9.49±0.64 vs. 6.31±0.51, p<0.001) and correlated statistically significant with pain intensity (r=0.36, p<0.001). There was a moderate correlation between depression and motor scores (r=0.43, p<0.001) and depression and health related quality of life (r=0.65, p<0.001).

This study underlies the importance of addressing neuropshychiatric disturbances such as anxiety and depression in patients with PD and chronic pain, since they contribute to both clinical picture of pain and health related quality of life.

To cite this abstract in AMA style:

G. Pavlic, I. Moldovanu, N. Diaconu, L. Rotaru. Neuropsychiatric disturbances in Parkinson’s disease patients’ with chronic pain [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/neuropsychiatric-disturbances-in-parkinsons-disease-patients-with-chronic-pain/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuropsychiatric-disturbances-in-parkinsons-disease-patients-with-chronic-pain/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley